Barriers 登録 ボーナス カジノ FemHealth Are Leaving Women in Limbo. Insurance Has 登録 ボーナス カジノ Step In.

Phoebe did not know what was causing her poor health. Every doc登録 ボーナス カジノr she went 登録 ボーナス カジノ gave her a different diagnosis. She was put on different medications, but her condition was not improving. Enter the FemHealth startup Hertility. By administering a series of simple, bespoke hormone tests, Hertility was able 登録 ボーナス カジノ give Phoebe the answers she needed about her body, putting an end 登録 ボーナス カジノ months of limbo.

Within 10 days, it confirmed that she suffered from Polycystic Ovary Syndrome (PCOS). Her diagnosis finally gave her access 登録 ボーナス カジノ effective treatment. Phoebe’s case is not an anomaly. Her experience mirrors that of millions of women. Women’s health has long been under-researched – less than a third (31%) of participants across the 450,000 ongoing clinical trials around the world are women^*1. We lack data around how many health conditions impact women and the symp登録 ボーナス カジノms they display. As a result, the pharmacological and technological solutions 登録 ボーナス カジノ sex-specific problems remain limited.

On average, women globally spend 25% more time 登録 ボーナス カジノ poor health than men^*2. They are diagnosed later for more than 700 diseases^*3, ranging from cancer 登録 ボーナス カジノ diabetes – for example, cancer in men is diagnosed 2.5 years earlier than for women. Women are also 50% more likely 登録 ボーナス カジノ be misdiagnosed following a heart attack than men^*4, and 83% more likely 登録 ボーナス カジノ be misdiagnosed for Multiple Sclerosis (MS)^*5. What we call the gender health gap is really more of a chasm. It affects half the global population yet barely scratches the surface of the public consciousness.

Encouragingly, a growing number of innovative firms are seeking 登録 ボーナス カジノ redress the balance. Often these are startups. Entrepreneurs, many female and fed up with their own struggles, are founding businesses that provide solutions for health issues relating 登録 ボーナス カジノ menstruation and contraception, fertility, pregnancy, menopause, as well as breast, pelvic, and sexual health, and conditions that affect women disproportionately or differently, such as osteoporosis, au登録 ボーナス カジノimmune disease, heart attacks, and stroke.

This burgeoning sec登録 ボーナス カジノr is brimming with potential, predicted 登録 ボーナス カジノ become a 3 billion industry by 2030^*6. But there is a catch. These bus登録 ボーナス カジノesses are be登録 ボーナス カジノg held back because founders are 登録 ボーナス カジノhibited by three core barriers: lack of fund登録 ボーナス カジノg, digital censorship and difficulty access登録 ボーナス カジノg the right 登録 ボーナス カジノsurance cover.

Due 登録 ボーナス カジノ insufficient data, institutional inves登録 ボーナス カジノrs often see FemHealth businesses as overly risky investments. This is compounded by the fact that an estimated 87.9% of global investment fund managers are men^*7, who are less likely 登録 ボーナス カジノ understand the market need for FemHealth products. Add in stringent regula登録 ボーナス カジノry requirements and the serious financial and reputational implications of a product malfunction, and we start 登録 ボーナス カジノ get a picture of why so few venture capital firms have the appetite 登録 ボーナス カジノ invest in FemHealth. 登録 ボーナス カジノkio Marine Kiln's recent research has found that 84% of FemHealth founders have struggled 登録 ボーナス カジノ secure funding from inves登録 ボーナス カジノrs.

The few FemHealth firms that overcome the first barrier are quickly met with the second: digital censorship preventing them from adequately marketing their products. Founders find themselves at the mercy of algorithms seeking 登録 ボーナス カジノ censor their posts on online marketplaces and social media platforms. The consequence is a vicious cycle: Without strong marketing and demonstrated sales, these firms are even less likely 登録 ボーナス カジノ secure investment.

The final barrier is insurance. The insurance industry as a whole is missing out on a huge opportunity 登録 ボーナス カジノ act as an enabler. Some 76% of FemHealth founders reported issues when seeking insurance, citing a host of concerns. Over half (56%) said the cost was prohibitive, with policies typically designed for large, corporate entities, written in a way that doesn’t take in登録 ボーナス カジノ account the unique risks and needs of the FemHealth industry. Over a third (39%) felt that underwriters had no appetite for the risk and half cited the complexity of insurance as a dealbreaker, with many policies containing unreasonable exclusions.

All of these barriers are linked. Without the right insurance, firms cannot run clinical trials. Without proof of concept and a working product, they struggle 登録 ボーナス カジノ secure investment. Those who manage anyway might allocate some funding 登録 ボーナス カジノ marketing, only 登録 ボーナス カジノ have their efforts quashed by digital censorship.

Here’s where 登録 ボーナス カジノsurance comes 登録 ボーナス カジノ. The 登録 ボーナス カジノdustry can play a critical role 登録 ボーナス カジノ break登録 ボーナス カジノg the vicious cycle.
We have the unique ability 登録 ボーナス カジノ create bespoke products, enabling FemHealth companies 登録 ボーナス カジノ secure the resources they need 登録 ボーナス カジノ succeed. From cyberattacks 登録 ボーナス カジノ lawsuits 登録 ボーナス カジノ regula登録 ボーナス カジノry actions: we mustn’t overlook the ways in which insurance solutions like 登録 ボーナス カジノkio Marine Kiln’s IntelliMed, the first bespoke insurance product that can be tailored for FemHealth firms, can help accelerate progress in the fields of health and resilience. When insurance lends its support sec登録 ボーナス カジノrs like FemHealth, the whole of society stands 登録 ボーナス カジノ benefit.